| |
| |
|
| Insider
Information: |
Cuss Francis M |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
331,905 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,438,009 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
331,905 |
|
|
| Total
Value |
$14,438,009 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP & CSO |
2017-03-10 |
321,905 |
|
0 |
Premium* |
|
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2018-07-20 |
10,000 |
2018-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2018-07-20 |
4 |
B |
$23.00 |
$230,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,484) |
301,379 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
66,726 |
346,770 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2017-03-10 |
4 |
D |
$58.32 |
$2,009,241 |
D/D |
(34,452) |
321,906 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,384 |
297,113 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-07-01 |
4 |
D |
$73.78 |
$139,887 |
D/D |
(1,896) |
289,732 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,655 |
291,628 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,632 |
277,114 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(78) |
278,892 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,143 |
300,492 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-03-10 |
4 |
D |
$64.94 |
$1,336,855 |
D/D |
(20,586) |
287,973 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-03-06 |
4 |
D |
$64.71 |
$197,107 |
D/D |
(3,046) |
268,861 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,864 |
271,907 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2016-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,010 |
269,043 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-16 |
4 |
OE |
$24.74 |
$2,909,160 |
D/D |
114,010 |
380,699 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-16 |
4 |
S |
$67.81 |
$7,775,501 |
D/D |
(114,666) |
266,033 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-10 |
4 |
D |
$65.53 |
$350,389 |
D/D |
(5,347) |
266,689 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,292 |
269,714 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,019 |
269,160 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,009 |
261,937 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,802 |
264,739 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-06 |
4 |
D |
$65.12 |
$196,272 |
D/D |
(3,014) |
261,725 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-02 |
4 |
D |
$62.30 |
$171,886 |
D/D |
(2,759) |
246,302 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,703 |
249,061 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & CSO |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,703 |
245,358 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
